previous speaker
Professor of Pharmacology and Toxicology, Department of Pharmacology, Baqiyatallah Medical Science University Tehran - Iran
Advisor to Managing Director, Iran Blood Transfusion Organization, Iran
Advisor to Managing Director, Iran Blood Transfusion Organization, Iran
Professor Abdol Majid Cheraghali was awarded his PharmD in 1988, from the Faculty of Pharmacy, University of Tehran, Iran, and his PhD in 1994 from the Faculty of Pharmacy and Pharmaceutical Science, University of Alberta, Edmonton, Canada. Additionally, he has had a Post-doctoral fellowship in the Department of Pharmacology, at the University of Alberta, Edmonton, Canada (1994-1995). Professor Cheraghali received a WHO fellowship to study pharmacoeconomics at the University of Newcastle, Australia (2003).
Currently, Professor Cheraghali is Professor of Pharmacology and Toxicology, Department of Pharmacology, BMS University, Tehran, Iran; Advisor to Managing Director of Iran Blood Transfusion Organization, Iran (since 2006); member of WHO Expert Panel on Drug Evaluation (since 2008), and Pharmacy Education Advisory Board of Iran Ministry of Health and Medical Education (since 1998).
Previously, Professor Cheraghali has been Chair of the National Committee for revising national drug policy (2003), Director General of the National Food and Drug Control Laboratories, Ministry of Health and Medical Education (1999–2003), Director of the Iran Drug Selection Committee, Ministry of Health and Medical Education (1996–1999), Director of Office of Rational Drug Use, Department of Food and Drug, Ministry of health and Medical Education (1998–1999), and Chair of Department of Pharmacology and Toxicology, BMS University (1996–2000).
Major Interests
National Drug Policy Developments, Rational Drug Use, National Regulatory Authority, Regulation of Pharmaceuticals , Blood and Biological Products, Globalization and Public Health, Phramcoeconomics ,Pharmacology and Toxicology.
Currently, Professor Cheraghali is Professor of Pharmacology and Toxicology, Department of Pharmacology, BMS University, Tehran, Iran; Advisor to Managing Director of Iran Blood Transfusion Organization, Iran (since 2006); member of WHO Expert Panel on Drug Evaluation (since 2008), and Pharmacy Education Advisory Board of Iran Ministry of Health and Medical Education (since 1998).
Previously, Professor Cheraghali has been Chair of the National Committee for revising national drug policy (2003), Director General of the National Food and Drug Control Laboratories, Ministry of Health and Medical Education (1999–2003), Director of the Iran Drug Selection Committee, Ministry of Health and Medical Education (1996–1999), Director of Office of Rational Drug Use, Department of Food and Drug, Ministry of health and Medical Education (1998–1999), and Chair of Department of Pharmacology and Toxicology, BMS University (1996–2000).
Major Interests
National Drug Policy Developments, Rational Drug Use, National Regulatory Authority, Regulation of Pharmaceuticals , Blood and Biological Products, Globalization and Public Health, Phramcoeconomics ,Pharmacology and Toxicology.
E-mail: majidcheraghali@gmail.com; m.cheraghali@bmsu.ac.ir
Abdol Majid Cheraghali
PhD, Pharmacoeconomics and Pharmaceutical Administration
CIO at Iran Food and Drug Administration (IFDA)
Assistant Professor in Department of Pharmacoeconomics and Pharmaceutical Administration , Pharmacy school, Tehran University of Medical science (TUMS)
Experienced Assistant Professor with a demonstrated history of working in the higher education industry. Skilled in Business Planning, Market Analysis, and Healthcare Information Technology (HIT). Administrative professional with a Doctor of Philosophy (PhD) focused in pharmacoeconomics and Pharmaceutical administration from Tehran University of Medical sciences.
Assistant Professor in Department of Pharmacoeconomics and Pharmaceutical Administration , Pharmacy school, Tehran University of Medical science (TUMS)
Experienced Assistant Professor with a demonstrated history of working in the higher education industry. Skilled in Business Planning, Market Analysis, and Healthcare Information Technology (HIT). Administrative professional with a Doctor of Philosophy (PhD) focused in pharmacoeconomics and Pharmaceutical administration from Tehran University of Medical sciences.
akbar abdollahiasl
Hossein Vahidi
Ph.D in Pharmacology
Professor of Pharmacology, Department of Pharmacology and Toxicology, School of Pharmacy & Pharmaceutical Sciences, Isfahan University of Medical Sciences. Dean of School of Pharmacy, Isfahan University of Medical Sciences
Email: minaiyan@pharm.mui.ac.ir
Mohsen Minaiyan
Current position:
Pediatric Hematologist/Oncologist Associate Professor of Medicine Tehran University of Medical Sciences
Pediatric Hematology-Oncology and Stem Cell Transplantation at Tehran University of Medical Sciences
Pediatric Hematologist/Oncologist Associate Professor of Medicine Tehran University of Medical Sciences
Pediatric Hematology-Oncology and Stem Cell Transplantation at Tehran University of Medical Sciences
Research Interest:
Stem cell, Regenerative medicine and Immunology
Stem cell, Regenerative medicine and Immunology
Email: aahamidieh@sina.tums.ac.ir
Tel: 21 84902647
Fax: 21 88004140
Tel: 21 84902647
Fax: 21 88004140
Amir Ali Hamidieh
Position:
Director of monoclonal Antibody Research Center, Avicenna Research Institute
Administration:
Head of diagnostic lab of Iran University of medical science.
Head of Department of Immunology, Avesina Research Center.
Head of Monoclonal Antibody Research Center.
Member of Medical Biotechnology board of Iran.
Director of monoclonal Antibody Research Center, Avicenna Research Institute
Administration:
Head of diagnostic lab of Iran University of medical science.
Head of Department of Immunology, Avesina Research Center.
Head of Monoclonal Antibody Research Center.
Member of Medical Biotechnology board of Iran.
Ph.D. in Immunology, Microbiology and Tumorbiology Center (MTC), Karolinska Institute, Stockholm, Sweden.
Email: Mahmood.Jeddi-Tehrani@ki.se
Mahmood Jeddi Tehrani
Doctor of Philosophy(PhD), Pharmacy Ethics
Senior Lecturer in Pharmacy Practice at the University of Sydney
Faculty of Pharmacy - The University of Sydney
Senior Lecturer in Pharmacy Practice at the University of Sydney
Faculty of Pharmacy - The University of Sydney
Biographical details:
Dr Betty Chaar is a pharmacist and lecturer in professionalism in pharmacy. She holds a master’s degree in Health Law and her PhD is about developing moral reasoning capabilities and ethical decision-making in pharmacy practice. Betty has working in the field of pharmacy for many years, with experience in community pharmacy ownership, hospital pharmacy, pharmaceutical industry, academia and research.
Dr Chaar is an active member on a number of Human Research Ethics committees. She is immediate past President of the Australian Association for Professional and Applied Ethics [AAPAE]; member of the Australian Pharmacy Council [APC] Examining Committee; serves on the Peer Review committee of the Pharmacy Board [AHPRA]; and a member of the Executive Committee of the Social and Administrative Pharmacy Section of the International Pharmaceutical Federation [FIP].
In July 2012, Betty co-chaired the Global Working Group on Pharmacy Ethics and Autonomy for FIP in The Hague, and continues this ongoing work. Betty also works with NSW Health on Opioid Substitution Treatment services in pharmacy. She currently conducts research on a number of practice-based projects, such as health literacy, weight management, hospital pharmacy, direct-to-consumer advertising and the needs of patients from various ethnic backgrounds.
Research interests
Ethics in Pharmacy: explores all aspects of professional ethics in practice, including ethical decision-making, dilemmas in practice and codes of ethics.
Hospital Pharmacy: explores the role of the Basel Statements [FIP, 2008] in the conduct of hospital pharmacy around the world. Our research group has established TheWorld Hospital Pharmacy Research Consortium (WHoPReC)to research the impact and uptake of these statements around the globe. Another study is investigating the collaborative roles of ward pharmacists and nurses in hospital pharmacy. Opioid Substitution Treatment [OST] services in pharmacy: this research explores reasons for lack of uptake of OST services in community pharmacy in Australia. There is a well-documented ‘unmet need’ for more services to be provided, and an opportunity for pharmacists to expand services provision.
Health Literacy in Pharmacy: this project has attracted funding from the Guild Government grant program, and explores the role of pharmacists and pharmacy assistants in promoting health literacy in ethnic communities. Impairment in Pharmacy: this study explores various aspects of impairment of pharmacists, support services available and the impact of mandatory reporting.
Weight Management Services in Pharmacy: this research is testing the feasibility of introducing a non-product centred service to assist consumers’ weight management.
Dr Betty Chaar is a pharmacist and lecturer in professionalism in pharmacy. She holds a master’s degree in Health Law and her PhD is about developing moral reasoning capabilities and ethical decision-making in pharmacy practice. Betty has working in the field of pharmacy for many years, with experience in community pharmacy ownership, hospital pharmacy, pharmaceutical industry, academia and research.
Dr Chaar is an active member on a number of Human Research Ethics committees. She is immediate past President of the Australian Association for Professional and Applied Ethics [AAPAE]; member of the Australian Pharmacy Council [APC] Examining Committee; serves on the Peer Review committee of the Pharmacy Board [AHPRA]; and a member of the Executive Committee of the Social and Administrative Pharmacy Section of the International Pharmaceutical Federation [FIP].
In July 2012, Betty co-chaired the Global Working Group on Pharmacy Ethics and Autonomy for FIP in The Hague, and continues this ongoing work. Betty also works with NSW Health on Opioid Substitution Treatment services in pharmacy. She currently conducts research on a number of practice-based projects, such as health literacy, weight management, hospital pharmacy, direct-to-consumer advertising and the needs of patients from various ethnic backgrounds.
Research interests
Ethics in Pharmacy: explores all aspects of professional ethics in practice, including ethical decision-making, dilemmas in practice and codes of ethics.
Hospital Pharmacy: explores the role of the Basel Statements [FIP, 2008] in the conduct of hospital pharmacy around the world. Our research group has established TheWorld Hospital Pharmacy Research Consortium (WHoPReC)to research the impact and uptake of these statements around the globe. Another study is investigating the collaborative roles of ward pharmacists and nurses in hospital pharmacy. Opioid Substitution Treatment [OST] services in pharmacy: this research explores reasons for lack of uptake of OST services in community pharmacy in Australia. There is a well-documented ‘unmet need’ for more services to be provided, and an opportunity for pharmacists to expand services provision.
Health Literacy in Pharmacy: this project has attracted funding from the Guild Government grant program, and explores the role of pharmacists and pharmacy assistants in promoting health literacy in ethnic communities. Impairment in Pharmacy: this study explores various aspects of impairment of pharmacists, support services available and the impact of mandatory reporting.
Weight Management Services in Pharmacy: this research is testing the feasibility of introducing a non-product centred service to assist consumers’ weight management.
Tel: +61 2 9036 7101
Email: betty.chaar@sydney.edu.au
Email: betty.chaar@sydney.edu.au
Dr Betty Chaar
Academic Background
Post-Doctoral Training, Neuropharmacology Lab, College of Pharmacy and Pharmaceutical Sciences, Florida A&M University.
Ph.D., Pharmacology and Toxicology, Florida A&M University.
Professor , Shahid Beheshti University of Medical Sciences and Health Services, Iran
Post-Doctoral Training, Neuropharmacology Lab, College of Pharmacy and Pharmaceutical Sciences, Florida A&M University.
Ph.D., Pharmacology and Toxicology, Florida A&M University.
Professor , Shahid Beheshti University of Medical Sciences and Health Services, Iran
Research Interest:
Pharmacological and Toxicological Screening of synthetic and natural products Drug Utilization Review (DUR) studies of Narcotics and Antiinfectives Epidemiological studies of Opioid use and abuse Jugular vein and carotid artery catheterization in rats and rabbits Metabolic aspects of selenium toxicity Analytical techniques using radioimmunoassay Analysis of mediators of glucoregulation Development of an anesthetic procedure for rabbits (5-hour anesthesia) Assessment of neurochemical and behavioral changes in the CNS Brain microdialysis in rats Analysis of neurotransmitters in CNS using HPLC-ECD Applications of softwares (both IBM and Macintosh) in health sciences
Pharmacological and Toxicological Screening of synthetic and natural products Drug Utilization Review (DUR) studies of Narcotics and Antiinfectives Epidemiological studies of Opioid use and abuse Jugular vein and carotid artery catheterization in rats and rabbits Metabolic aspects of selenium toxicity Analytical techniques using radioimmunoassay Analysis of mediators of glucoregulation Development of an anesthetic procedure for rabbits (5-hour anesthesia) Assessment of neurochemical and behavioral changes in the CNS Brain microdialysis in rats Analysis of neurotransmitters in CNS using HPLC-ECD Applications of softwares (both IBM and Macintosh) in health sciences
Email: rasekh@sbmu.ac.ir
Tel: 88200088-021
Tel: 88200088-021
Hamid Reza Rasekh
A committed and hard-working doctor, I possess more than eleven years experience in the field of urology, with a special interest in gemale urology. I am the only female urologist at the Mashad University of Medical Sciences which is one of the five largest universities in Iran.
In my role as Assistant Professor of Urology at Mashad University of Medical Sciences, a post I took up in May 2009, I hold frequent formal and informal teaching sessions for medical students and urology residents and have taught different kinds of urology operations, including: endourology, female urology, paediatric urology and reconstructive urology. My wide experience in clinical and surgical urology has led me to write and publish many papers which is a commitment I intend to carry on throughout my career.
In my role as Assistant Professor of Urology at Mashad University of Medical Sciences, a post I took up in May 2009, I hold frequent formal and informal teaching sessions for medical students and urology residents and have taught different kinds of urology operations, including: endourology, female urology, paediatric urology and reconstructive urology. My wide experience in clinical and surgical urology has led me to write and publish many papers which is a commitment I intend to carry on throughout my career.
EDUCATION AND QUALIFICATIONS
Board Certification in Urology
MD (with full licence to practice)
Board Certification in Urology
MD (with full licence to practice)
Tel: 511 761 5063 , 915 315 2081
Email: keshvarimd@yahoo.com
Email: keshvarimd@yahoo.com
Maliheh Keshvari Shirvan
Ph.D. Immunology; Experimental Pathology, Department of Pathology, University of Medicine and Dentistry of New Jersey, New Jersey Medical School (UMDNJ), Newark, N.J., USA
Academic Position:
Faculty Associate Professor, Biotechnology Depart., Pasteur Institute of Iran, Tehran, Iran
Area of Research:
1. Scale up and process development for recombinant proteins
2. Molecular analysis of kDNA of Leishmania species
3. Heterologous gene expression: Gene expression Second generation vaccine development, and Recombinant protein for pharmaceutical purposes expression
4. Expression of recombinant proteins for biopharmaceutics in mammalian and bacteria
Faculty Associate Professor, Biotechnology Depart., Pasteur Institute of Iran, Tehran, Iran
Area of Research:
1. Scale up and process development for recombinant proteins
2. Molecular analysis of kDNA of Leishmania species
3. Heterologous gene expression: Gene expression Second generation vaccine development, and Recombinant protein for pharmaceutical purposes expression
4. Expression of recombinant proteins for biopharmaceutics in mammalian and bacteria
Email: mahboudif@cinnagen.com
Fereidoun Mahboudi
Ph.D. degree in Nuclear Pharmacy
SKILLS
• Preparation and quality control of PET and non PET Radiopharmaceuticals Radiolabeling of proteins, oligonucleotides
• Biodistribution studies
• Mammalian tissue culture
• Hybridoma cell fusion technology
• Production, purification and character rization of monoclonal antibodies
• Immunoprecipitation
• Electrophoresis
• ELIZA
• Western and dot blot analysis
Research Interest :
-) Radioligand receptor binding assay
-) Preparation and characterization of Monoclonal antibodies
-) Preparation and quality control of PET Radiopharmaceuticals
-)Radiolabeling of proteins, peptides, antibodies, and nucleotides with different radionuclides such as 99m-Tc, 125-I, 111-In, 18-F
-) Evaluation of Pharmaceutical formulations with 99m-Tc, 125-I, 111-In, 18-F
• Preparation and quality control of PET and non PET Radiopharmaceuticals Radiolabeling of proteins, oligonucleotides
• Biodistribution studies
• Mammalian tissue culture
• Hybridoma cell fusion technology
• Production, purification and character rization of monoclonal antibodies
• Immunoprecipitation
• Electrophoresis
• ELIZA
• Western and dot blot analysis
Research Interest :
-) Radioligand receptor binding assay
-) Preparation and characterization of Monoclonal antibodies
-) Preparation and quality control of PET Radiopharmaceuticals
-)Radiolabeling of proteins, peptides, antibodies, and nucleotides with different radionuclides such as 99m-Tc, 125-I, 111-In, 18-F
-) Evaluation of Pharmaceutical formulations with 99m-Tc, 125-I, 111-In, 18-F
Phone: 021 88200094 , Mobile: 0912 549 3958
E-mails: soraya.shahhosseini@gmail.com
E-mails: soraya.shahhosseini@gmail.com
Soraya Shahhosseini
Dean of School of Pharmacy, KazNMU
Doctor of Pharmacy
Technology of dosage forms and organization of pharmaceutical business
Doctor of Pharmacy
Technology of dosage forms and organization of pharmaceutical business
Research interests:
• Development of new drugs
• Development of state requirements for quality and safety of medicines
• Development of the RK Pharmacopeia index for the Global World Pharmacopoeia Index
• Development of new drugs
• Development of state requirements for quality and safety of medicines
• Development of the RK Pharmacopeia index for the Global World Pharmacopoeia Index
Sakipova Zuriyadda Bektemirovna
Ph.D, Pharmacology
Professor, pharmacology , Department of Toxicology & pharmacology
Tehran University of Medical Sciences, Tehran, Iran
Professor, pharmacology , Department of Toxicology & pharmacology
Tehran University of Medical Sciences, Tehran, Iran
Research Interests:
1. pharmaceutical manement
2. pharmacoeconomy
3. Neurotoxicology
4. Neuropharmacology; epilepsy, anxiety, movement disorders
1. pharmaceutical manement
2. pharmacoeconomy
3. Neurotoxicology
4. Neuropharmacology; epilepsy, anxiety, movement disorders
E-mail:kebriaee@tums.ac.ir
Abbas Kebriaeezadeh
Fellowship, Health Economic – Center for Health Economics (CHE)- York University.
MD, Medical, Doctorate- Yazd Medical University
-) Vice Deputy for Planning (MOH)
-) Mebmber of board – Iranian Health Economic Assocciation
-) Member of Strategic Council- National Research Network for Policy Making, Economics & Health Management
-) CEO & Member of the board – Shian's Diagnosis and treatment Institute.
MD, Medical, Doctorate- Yazd Medical University
-) Vice Deputy for Planning (MOH)
-) Mebmber of board – Iranian Health Economic Assocciation
-) Member of Strategic Council- National Research Network for Policy Making, Economics & Health Management
-) CEO & Member of the board – Shian's Diagnosis and treatment Institute.
experienced Council Member with a demonstrated history of working in the hospital & health care industry, Health and Social welfare System. Skilled in Negotiation, Strategic Planning, Health Policy, Microsoft Word, leadership & Coaching, and Epidemiology. Strong business development professional with a Fellowship focused in health economics from Center for Health Economics(CHE)-York University.
Hamidreza Safikhani
Scientific advisor of Iranian Council for Development of the Stem Cell Sciences and Technologies Applied Cell Sciences & Tissue Engineering Department, School of Advanced Technologies in Medicine Tehran University of Medical Sciences (TUMS), Tehran, IRAN
PhD, Applied Cell Science
PhD, Applied Cell Science
Research Interest:
NK cell, NKT cells, CAR NKs, NK-B cell hybridoma
CAR-T cells
Hematopoietic Stem Cell engineering for Malignant and Non-malignant disorders
NK cell, NKT cells, CAR NKs, NK-B cell hybridoma
CAR-T cells
Hematopoietic Stem Cell engineering for Malignant and Non-malignant disorders
Tel: 9121454878, 9351013393 , 21-83532371
Email: Shoae@stemcell.isti.ir , cell.therapy@yahoo.com
Email: Shoae@stemcell.isti.ir , cell.therapy@yahoo.com
Alireza Shoae-Hassani
Head of Cell Therapy Development at Lonza, Lonza, The University of Calgary
Dr. Behnam Baghbaderani is the head of Cell Therapy Development, Emerging Technologies at Lonza. He has over 14 years of experience in bioengineering and custom manufacturing for cell therapy application. Dr. Baghbaderani holds a PhD degree in Biomedical Engineering from the University of Calgary (Calgary, Canada), where he developed bioreactor protocols for large-scale expansion of human neural stem cells for clinical applications. He completed nearly three years postdoctoral program including a two-year postdoctoral fellowship at the National Institutes of Health (NIH) / National Institute of Neurological Disorders and Stroke (NINDS). His postdoctoral research at the NIH focused on generation of human induced pluripotent stem cells (hiPSCs), bioprocessing of both human embryonic stem cells and hiPSCs and controlled differentiation into neuronal lineage. Since joining Lonza in 2011, he has been working on developing new technologies and manufacturing processes around human pluripotent stem cells, adult stem cells, and CAR-T applications. As the head of CT Development, Dr. Baghbaderani is currently leading the process development and bioassay services, focusing on the development of cGMP compliant processes and cell characterization assays for allogeneic and autologous cell therapy applications.
• Head of Cell Therapy Development department including process development and Bioassay services
• Process development and optimization for cGMP manufacturing of Cell Therapy products
• Develop, optimize, tech transfer processes to cGMP manufacturing facility for a wide range of cell therapy applications .
• Assay development, assay optimization, and assay qualification activities for cell Therapy applications.
• Project management of GMP and R&D projects.
• About five years of experience in generation and expansion of human induced pluripotent stem cells (hiPSC); expansion of pluripotent stem cells in small or large scale Cell Factory system, and differentiation into neural lineages.
• More than 14 years of experience in bioprocessing, scale-up, and bioreactor expansion of various mammalian cells including highly sensitive human pluripotent stem cells and human neural stem / progenitor cells.
• More than two years of postdoctoral research experience including the current post-doc at the National Institute of Health.
• Professional training and four years of industrial and managerial experience in downstream operation for protein purification (under GMP regulations) at the Pasteur Institute of Iran – Production Complex.
• Excellent scientific publication records, communication and organizational skills, and leadership experience in a team setting.
Specialties: process development and optimization, experimental design, hiPSC generation, Bioreactors, Scale up, Medium Optimization, Bioprocessing, Protein Purification, Cell Characterization
• Head of Cell Therapy Development department including process development and Bioassay services
• Process development and optimization for cGMP manufacturing of Cell Therapy products
• Develop, optimize, tech transfer processes to cGMP manufacturing facility for a wide range of cell therapy applications .
• Assay development, assay optimization, and assay qualification activities for cell Therapy applications.
• Project management of GMP and R&D projects.
• About five years of experience in generation and expansion of human induced pluripotent stem cells (hiPSC); expansion of pluripotent stem cells in small or large scale Cell Factory system, and differentiation into neural lineages.
• More than 14 years of experience in bioprocessing, scale-up, and bioreactor expansion of various mammalian cells including highly sensitive human pluripotent stem cells and human neural stem / progenitor cells.
• More than two years of postdoctoral research experience including the current post-doc at the National Institute of Health.
• Professional training and four years of industrial and managerial experience in downstream operation for protein purification (under GMP regulations) at the Pasteur Institute of Iran – Production Complex.
• Excellent scientific publication records, communication and organizational skills, and leadership experience in a team setting.
Specialties: process development and optimization, experimental design, hiPSC generation, Bioreactors, Scale up, Medium Optimization, Bioprocessing, Protein Purification, Cell Characterization
Email: behnam.ahmadianbaghbaderani@lonza.com
Behnam A. Baghbaderani
Ph.D cDepartment of Pharmaceutical Biotechnology, Faculty of Pharmacy, Tehran University of Medical Science, Tehran, Iran
Associate professor
Department of Dental Biomaterial, Dental School, Shahid Beheshti University of Medical Sciences
Research Interests:
• Cellular and Molecular Biology
• Genomics, Proteomics, Pharmacogenetics
• Cancer Research/Therapy, Gene/Stem cell Therapy
• Protein engineering and Recombinant Protein Drugs
c • Drug/Gene/protein delivery in Tissue Engineering
Department of Dental Biomaterial, Dental School, Shahid Beheshti University of Medical Sciences
Research Interests:
• Cellular and Molecular Biology
• Genomics, Proteomics, Pharmacogenetics
• Cancer Research/Therapy, Gene/Stem cell Therapy
• Protein engineering and Recombinant Protein Drugs
c • Drug/Gene/protein delivery in Tissue Engineering
Email: torshabi@sbmu.ac.ir , maryam_torshabi@yahoo.com
Maryam Torshabi
Assistant Professor, Head of Department
Tarbiat Modares University , Tehrān · Department of Nanobiotechnology
Speciality: Protein Self Assembly-Protein engineering
• BS/BA: Cell and Molecular Biology
• MS: Biophysics
• PhD: Biophysics
Tarbiat Modares University , Tehrān · Department of Nanobiotechnology
Speciality: Protein Self Assembly-Protein engineering
• BS/BA: Cell and Molecular Biology
• MS: Biophysics
• PhD: Biophysics
Phone: +98 21 82884734
Fax: +98 21 82884457
Email: m_nikkhah@modares.ac.ir
Fax: +98 21 82884457
Email: m_nikkhah@modares.ac.ir
Maryam Nikkhah
MD, MPH, D.Sc
(Medical Doctorate, Masters of Public Health in Medical University of Tehran, Maters of Health sciences in Harvard School of Public Health, Doctor of Sciences in Harvard school of Public Health)
Associate Professor
Chair of Non-Communicable Diseases Research Center, Tehran University of Medical Sciences, Tehran, Iran
(Medical Doctorate, Masters of Public Health in Medical University of Tehran, Maters of Health sciences in Harvard School of Public Health, Doctor of Sciences in Harvard school of Public Health)
Associate Professor
Chair of Non-Communicable Diseases Research Center, Tehran University of Medical Sciences, Tehran, Iran
Biography
Farshad Farzadfar (MD, MPH, D.Sc.), has got his Medical Doctorate degree from Tehran University of Medical Sciences. Then he started studying Master of Public Health in the same university. Being awarded the opportunity of studying at Harvard school of Public Health, he graduated in Master of Health Sciences and Doctor of Sciences in 2011. Coming back to Iran, he participated in different research projects and in 2012 he established Non-Communicable Diseases Research Center of Endocrinology and Metabolism research Institute, Tehran University of Medical Sciences (NCDRC). His main interests are in health metrics, burden of diseases, and health policy. Now he attempts to design and implement population level interventions in order to decrease the NCDs among society.
Career Interests
1- Health metrics
2- Burden of diseases, risk factors, and injuries
3- Cost Analysis
4- Health economics
5- Monitoring and Evaluation of Health Program
6- Health management and Health policy
7- NCDs Related Researches
Farshad Farzadfar (MD, MPH, D.Sc.), has got his Medical Doctorate degree from Tehran University of Medical Sciences. Then he started studying Master of Public Health in the same university. Being awarded the opportunity of studying at Harvard school of Public Health, he graduated in Master of Health Sciences and Doctor of Sciences in 2011. Coming back to Iran, he participated in different research projects and in 2012 he established Non-Communicable Diseases Research Center of Endocrinology and Metabolism research Institute, Tehran University of Medical Sciences (NCDRC). His main interests are in health metrics, burden of diseases, and health policy. Now he attempts to design and implement population level interventions in order to decrease the NCDs among society.
Career Interests
1- Health metrics
2- Burden of diseases, risk factors, and injuries
3- Cost Analysis
4- Health economics
5- Monitoring and Evaluation of Health Program
6- Health management and Health policy
7- NCDs Related Researches
Email : f-farzadfar@tums.ac.ir , farzadfar3@yahoo.com
Farshad Farzadfar
MD, PhD., President
He is a serial entrepreneur who successfully developed several companies representing and distributing some of the most well-known pharmaceutical products in the Middle East during the past 20 years. He is a medical doctor with PhD degree in Health Services Management,
Email: p_dindoust@behestandarou.com